CIK 0000885725 · Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042695240
- Phone
- 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | Mahoney Michael F Chairman, President & CEO | Gift | +149,992 | 149,992 | ||
| 2026-11-04 | Mahoney Michael F Chairman, President & CEO | Gift | +102,249 | 252,241 | ||
| 2026-11-01 | O'Sullivan Miriam SVP, Chief HR Officer | Option exercise | +3,871 | 21,437 | ||
| 2026-11-01 | O'Sullivan Miriam SVP, Chief HR Officer | Shares withheld for taxes | −1,872 | $41.98 | $79K | 19,565 |
| 2026-11-01 | O'Sullivan Miriam SVP, Chief HR Officer | Option exercise · Restricted Stock Units | −3,871 | 0 | ||
| 2026-09-02 | O'Connor Padraig Andrew EVP, Global Operations | Option exercise | +1,171 | 8,459 | ||
| 2026-09-02 | O'Connor Padraig Andrew EVP, Global Operations | Shares withheld for taxes | −567 | $48.37 | $27K | 7,892 |
| 2026-09-02 | O'Connor Padraig Andrew EVP, Global Operations | Option exercise · Restricted Stock Units | −1,171 | 3,516 | ||
| 2026-08-25 | Morano Susan E Director | Purchase | +2,040 | $49.22 | $100K | 13,784 |
| 2026-08-11 | Woodworth Emily SVP, Global Controller and CAO | Other acquisition | +2,930 | $51.19 | $150K | 2,930 |
| 2026-08-10 | Monson Jonathan EVP and CFO | Other acquisition | +9,908 | $50.46 | $500K | 9,908 |
| 2026-08-05 | Habiger David C Director | Purchase | +2,100 | $47.59 | $100K | 17,160 |
| 2026-08-04 | Habiger David C Director | Purchase | +140 | $48.59 | $7K | 15,060 |
| 2026-08-03 | Habiger David C Director | Purchase | +1,042 | $48.07 | $50K | 14,920 |
| 2026-08-03 | Mahoney Michael F Chairman, President & CEO | Purchase | +186,240 | $48.33 | $9.0M | 1,590,024 |
| 2026-08-03 | Mahoney Michael F Chairman, President & CEO | Other acquisition | +22,119 | $48.43 | $1.1M | 22,119 |
| 2026-07-31 | LUDWIG EDWARD J Director | Purchase | +5,000 | $45.48 | $227K | 30,359 |
| 2026-07-31 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Other acquisition | +64,198 | $46.73 | $3.0M | 64,198 |
| 2026-07-01 | Monson Jonathan EVP and CFO | Option exercise | +2,087 | 40,073 | ||
| 2026-07-01 | Monson Jonathan EVP and CFO | Shares withheld for taxes | −1,010 | $43.06 | $43K | 39,063 |
Page 1 of 40 · 791 trades